Chesley Taft & Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-4,026
| Closed | -$825K | – | 288 |
|
|
2017
Q3 | $825K | Sell |
4,026
-9,033
| -69% | -$1.85M | 0.07% | 188 |
|
|
2017
Q2 | $3.18M | Buy |
13,059
+3,482
| +36% | +$847K | 0.29% | 89 |
|
|
2017
Q1 | $2.29M | Sell |
9,577
-230
| -2% | -$54.9K | 0.22% | 101 |
|
|
2016
Q4 | $2.06M | Sell |
9,807
-21,362
| -69% | -$4.49M | 0.2% | 100 |
|
|
2016
Q3 | $7.18M | Buy |
31,169
+17,151
| +122% | +$3.95M | 0.72% | 44 |
|
|
2016
Q2 | $3.24M | Sell |
14,018
-186
| -1% | -$43K | 0.33% | 82 |
|
|
2016
Q1 | $3.81M | Sell |
14,204
-42
| -0.3% | -$11.3K | 0.4% | 70 |
|
|
2015
Q4 | $4.45M | Sell |
14,246
-4,206
| -23% | -$1.31M | 0.47% | 69 |
|
|
2015
Q3 | $5.02M | Buy |
18,452
+275
| +2% | +$74.7K | 0.55% | 61 |
|
|
2015
Q2 | $5.52M | Buy |
18,177
+201
| +1% | +$61K | 0.56% | 61 |
|
|
2015
Q1 | $5.35M | Buy |
17,976
+10,166
| +130% | +$3.03M | 0.55% | 61 |
|
|
2014
Q4 | $2.01M | Buy |
7,810
+35
| +0.5% | +$9.01K | 0.2% | 108 |
|
|
2014
Q3 | $1.88M | Buy |
7,775
+125
| +2% | +$30.2K | 0.2% | 107 |
|
|
2014
Q2 | $1.71M | Buy |
7,650
+50
| +0.7% | +$11.2K | 0.18% | 112 |
|
|
2014
Q1 | $1.56M | Sell |
7,600
-80
| -1% | -$16.5K | 0.17% | 116 |
|
|
2013
Q4 | $1.29M | Sell |
7,680
-120
| -2% | -$20.2K | 0.13% | 140 |
|
|
2013
Q3 | $1.12M | Sell |
7,800
-100
| -1% | -$14.4K | 0.12% | 148 |
|
|
2013
Q2 | $997K | Buy |
+7,900
| New | +$997K | 0.12% | 149 |
|